Contact details

Robert C. Griggs, M.D.

University of Rochester Department of Neurology
1351 Mt. Hope Avenue, Suite 203
Rochester, New York 14620
Office: 00 1 585 275 6072
Fax: 00 1 585 276-2056

Robert_Griggs@URMC.Rochester.edu

Representative Publications:

Venance SL, Cannon S, Fiahlo D, Fontaine B, Hanna MG, Ptacek L, Tristani-Firouzi M, Tawil R, Griggs RC: The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain 2006;129:8-17.

Venance SL, Herr BE, Griggs RC: Challenges in the design and conduct of therapeutic trials in channel disorders. Neurotherapeutics 2007;4:199-204.

Jen JC, Graves TD, Hess EJ, Hanna MG, Griggs RC, Baloh RW: Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain. 2007;130:2484-93

Griggs RC, Batshaw M, Dunkle M, Gopal-Srivastava R, Kaye E, Krischer J, Nguyen T, Paulus K, Merkel PA for the Rare Diseases Clinical Research Network.  Clinical Research for Rare Disease: Opportunities, Challenges, and Solutions.  Molecular Genetics and Metabolism, accepted for publication, 10/08.

Robert C. Griggs, M.D.

Robert C Griggs

Dr. Griggs is Professor of Neurology, Medicine, Pathology and Laboratory Medicine and Pediatrics at the University of Rochester School of Medicine and Dentistry. He was Chair of the Department of Neurology and Neurologist-in-Chief at Strong Memorial Hospital 1986-2008. He is currently President-Elect (2007-2009) of the American Academy of Neurology.

Dr. Griggs is an internist/neurologist specialising in neuromuscular diseases with a focus on experimental therapeutics. He has directed an NIH-funded training programme in the Experimental Therapeutics of Neurological Disease since 1989. He has published over 300 scientific papers and 23 texts which span the fields of medicine and neurology. He served as President of the Association of University Professor of Neurology (1994-1996). He has served on the Council of the American Neurological Association. He served as Editor-in-Chief of Neurology (1997-2007). He is Neurology Editor of Cecil Textbook of Medicine and an Editor of Cecil Essentials of Medicine. Dr. Griggs has received numerous awards for teaching including the American Academy of Neurology A.B. Baker Award and Lecture for Excellence in Teaching. He directed the educational programs of the AAN from 1992-1997. In 1998 he received the Robert Wartenberg Award and Lectureship of the AAN. In 2004 he delivered the Soriano Lectureship of the American Neurological Association. He was elected to the Institute of Medicine of the National Academy of Sciences in 1998.

Since 1998, Dr. Griggs has chaired the Executive Committee of the Muscle Study Group (MSG), an international consortium of investigators focused on developing new treatments for neuromuscular disease. The MSG (http://www.urmc.rochester.edu/msg) is supported by grants from the National Institute of Health, Food and Drug Administration, industry, and a number of foundations. Dr. Griggs serves on the Board of Directors of the American Society for NeuroTherapeutics (ASENT) and on the Editorial Board of NeuroTherapeutics. Dr. Griggs’ NIH grants are focused on developing treatments for neuromuscular channelopathies and other neuromuscular diseases.